Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Ljubljana Stock Exchange  >  Krka, d. d.    KRKG   SI0031102120

KRKA, D. D.

(KRKG)
  Report
End-of-day quote. End-of-day quote Ljubljana Stock Exchange - 01/21
95 EUR   +0.42%
2020KRKA D D : Reports Business Results for the First Nine Months Ended 30 September 2020
PU
2020KRKA, D. D. : quaterly earnings release
2020KRKA, D. D. : Ex-dividend day for final dividend
FA
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on KRKA, D. D.
01/28/21 FY 2020 Earnings Call - Preliminary
01/28/21 | 06:00am FY 2020 Earnings Release - Preliminary
03/18/21 | 02:15am FY 2020 Earnings Release
05/20/21 | 02:15am Q1 2021 Earnings Release
Past events on KRKA, D. D.
11/19/20 | 09:00am Q3 2020 Earnings Call
11/19/20 | 02:15am Q3 2020 Earnings Release
07/30/20 | 09:00am Interim 2020 Earnings Call
07/30/20 | 02:15am Interim 2020 Earnings Release
Upcoming sector events for KRKA, D. D.
01/22/21 | 01:00am WALVAX BIOTECHNOLOGY CO., LTD. : Extraordinary Shareholders Meeting
01/22/21 | 02:30am BETTA PHARMACEUTICALS CO., LTD. : Extraordinary Shareholders Meeting
01/26/21 | 08:00am NOVARTIS AG : FY 2020 Earnings Call
01/26/21 | 08:30am JOHNSON & JOHNSON : FY 2020 Earnings Call
More events
Past sector events for KRKA, D. D.
01/19/21 BRIDGEBIO PHARMA, INC. : Extraordinary Shareholders Meeting - M&A Vote
01/17/21 | 03:30pm ROCHE HOLDING AG : Gastrointestinal Cancers Symposium
01/15/21 | 04:30pm EISAI CO., LTD. : American society of clinical oncology virtual gastrointestinal cancers symposium - abstract #: 230
01/15/21 EISAI CO., LTD. : American society of clinical oncology virtual gastrointestinal cancers symposium - abstract #: 273
Annual publications
Annual results201520162017201820192020 (e)
Sales
M €
Released
Forecast
Spread
1 160
1 196
-3,0%
1 174
1 153
1,9%
1 266
1 258
0,68%
1 332
1 308
1,8%
1 493
1 485
0,59%

1 558
Operating income
(EBITDA)
M €
Released
Forecast
Spread
307
323
-5,0%
228
240
-4,8%
307
304
1,0%
343
322
6,5%
385
377
2,3%

471
Operating profit
(EBIT)
M €
Released
Forecast
Spread
199
215
-7,1%
122
131
-6,7%
199
193
3,1%
233
211
10%
274
265
3,5%

320
Pre-Tax Profit
(EBT)
M €
Released
Forecast
Spread
181
189
-4,3%
116
122
-4,3%


203
198
2,2%
284
284
0,24%


Net income
M €
Released
Forecast
Spread
158
169
-6,2%
108
103
4,9%
153
144
6,3%
174
165
5,6%
246
243
1,2%

255
EPS
Released
Forecast
Spread
4,86
5,15
-5,6%
3,35
3,17
5,6%
4,74
4,46
6,3%
5,46
5,05
8,1%
7,73
7,40
4,5%

7,76
Announcement Date03/03/201603/02/201703/22/201803/21/201903/19/2020

Quarterly publications
Previous periodNext period
Quarterly results2018 Q42019 S12019 Q32019 Q42020 Q1
Sales
M €
Released
Forecast
Spread
360
346
4,1%
761

329
316
4,3%
403
385
4,6%
463
438
5,7%
Operating income
(EBITDA)
M €
Released
Forecast
Spread
96,8
84,1
15%


64,5
68,6
-5,9%
111
97,0
15%
162
123
31%
Operating profit
(EBIT)
M €
Released
Forecast
Spread
69,1
56,1
23%


37,0
41,1
-9,9%
82,6
75,7
9,1%
134
94,9
41%
Pre-Tax Profit
(EBT)
M €
Released
Forecast
Spread
59,6
61,1
-2,5%








Net income
M €
Released
Forecast
Spread
53,2
51,9
2,5%








Announcement Date03/21/201908/01/201911/21/201903/19/202005/21/2020

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise